NVIDIA
NVDA
Tesla
TSLA
Taiwan Semiconductor
TSM
4
Palantir
PLTR
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
OCUL Ocular Therapeutix
- 6.500
- +0.575+9.70%
Close Mar 4 16:00 ET
- 6.520
- +0.020+0.31%
Post 19:26 ET
1.03BMarket Cap-5.33P/E (TTM)
6.630High5.785Low2.93MVolume5.820Open5.925Pre Close18.61MTurnover2.36%Turnover RatioLossP/E (Static)159.02MShares11.77552wk High3.28P/B806.79MFloat Cap4.06052wk Low--Dividend TTM124.12MShs Float44.190Historical High--Div YieldTTM14.26%Amplitude1.995Historical Low6.355Avg Price1Lot Size
Ocular Therapeutix Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.03%63.72M | 15.41%17.08M | 2.28%15.43M | 8.26%16.44M | 10.47%14.77M | 13.49%58.44M | 5.16%14.8M | 26.04%15.08M | 23.81%15.19M | 1.42%13.37M |
| Operating revenue | 9.03%63.72M | 15.41%17.08M | 2.28%15.43M | 8.26%16.44M | 10.47%14.77M | 13.49%58.44M | 5.16%14.8M | 26.04%15.08M | 23.81%15.19M | 1.42%13.37M |
| Cost of revenue | 6.53%5.63M | -11.26%1.23M | 13.36%1.56M | 15.72%1.51M | 9.23%1.33M | 16.32%5.28M | 36.96%1.39M | 28.33%1.38M | 12.90%1.3M | -6.62%1.21M |
| Gross profit | 9.28%58.1M | 18.17%15.85M | 1.17%13.86M | 7.56%14.93M | 10.59%13.45M | 13.22%53.16M | 2.69%13.42M | 25.82%13.7M | 24.94%13.88M | 2.30%12.16M |
| Operating expense | 69.60%229.88M | 98.50%66.43M | 81.85%59.86M | 69.87%58.52M | 29.84%45.07M | 7.91%135.54M | 3.21%33.47M | 1.49%32.92M | 11.04%34.45M | 16.79%34.71M |
| Selling and administrative expenses | 37.26%102.24M | 47.30%25.44M | 27.43%22.81M | 53.24%29.67M | 21.88%24.33M | 3.25%74.49M | -8.53%17.27M | -4.37%17.9M | 7.98%19.36M | 20.11%19.96M |
| -Selling and marketing expense | 5.94%5.12M | 15.50%1.32M | 23.98%1.25M | -13.65%1.28M | 5.94%1.27M | 15.89%4.83M | 104.53%1.14M | -90.09%1.01M | -85.40%1.48M | -86.80%1.2M |
| -General and administrative expense | 39.43%97.13M | 49.55%24.12M | 27.63%21.56M | 58.78%28.39M | 22.90%23.06M | 2.47%69.66M | -63.43%16.13M | 97.98%16.89M | 129.59%17.88M | 148.33%18.77M |
| Research and development costs | 109.05%127.64M | 153.10%40.99M | 146.71%37.05M | 91.18%28.86M | 40.60%20.74M | 14.20%61.06M | 19.58%16.2M | 9.48%15.02M | 15.22%15.09M | 12.57%14.75M |
| Operating profit | -108.52%-171.78M | -152.25%-50.58M | -139.40%-46M | -111.91%-43.59M | -40.21%-31.62M | -4.74%-82.38M | -3.56%-20.05M | 10.82%-19.21M | -3.28%-20.57M | -26.45%-22.55M |
| Net non-operating interest income expense | 191.16%6.71M | 158.14%1.57M | 209.71%2.43M | 328.48%2.84M | 89.29%-129K | -18.17%-7.36M | -89.04%-2.69M | -46.43%-2.21M | 23.41%-1.24M | 27.63%-1.21M |
| Non-operating interest income | 409.21%20.28M | 220.15%4.67M | 366.42%5.65M | 706.95%6.04M | 596.63%3.92M | 399.12%3.98M | 244.92%1.46M | 325.26%1.21M | 924.66%748K | 3,027.78%563K |
| Non-operating interest expense | 19.75%13.58M | -25.17%3.11M | -5.90%3.22M | 60.52%3.2M | 129.13%4.05M | 61.46%11.34M | 124.74%4.15M | 90.65%3.43M | 17.39%1.99M | 5.05%1.77M |
| Other net income (expense) | -415.85%-28.43M | 109.62%623K | -66.16%7.08M | -367.64%-3.03M | -404.30%-33.1M | -34.96%9M | -223.56%-6.48M | 1,947.35%20.91M | -59.21%1.13M | -194.36%-6.56M |
| Gain on sale of security | 90.75%-480K | 109.62%623K | 5.27%7.08M | -367.64%-3.03M | 21.50%-5.15M | -137.48%-5.19M | -223.56%-6.48M | 693.29%6.72M | -59.21%1.13M | -194.32%-6.56M |
| Special income (charges) | -296.97%-27.95M | --0 | --0 | --0 | ---27.95M | --14.19M | --0 | --14.19M | --0 | --0 |
| -Less:Other special charges | 296.97%27.95M | --0 | ---- | ---- | --27.95M | ---14.19M | --0 | ---14.19M | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | ---- | ---- | ---- | 0.00%-1K | --0 | ---- | ---- | 50.00%-1K |
| Income before tax | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Income tax | ||||||||||
| Net income | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Net income continuous Operations | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Basic earnings per share | -20.79%-1.22 | 17.14%-0.29 | -2,100.00%-0.22 | 0.00%-0.26 | -25.64%-0.49 | -9.78%-1.01 | -75.00%-0.35 | 96.77%-0.01 | -8.33%-0.26 | -143.75%-0.39 |
| Diluted earnings per share | -19.61%-1.22 | 17.14%-0.29 | 12.00%-0.22 | 0.00%-0.26 | -25.64%-0.49 | -5.15%-1.02 | -45.83%-0.35 | 19.35%-0.25 | -4.00%-0.26 | -77.27%-0.39 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |